Pathophysiology of X-linked adrenoleukodystrophy
Open Access
- 4 December 2013
- journal article
- review article
- Published by Elsevier BV in Biochimie
- Vol. 98 (100), 135-142
- https://doi.org/10.1016/j.biochi.2013.11.023
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (P26112-B19)
This publication has 94 references indexed in Scilit:
- Glutathione imbalance in patients with X-linked adrenoleukodystrophyMolecular Genetics and Metabolism, 2013
- Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophyBone Marrow Transplantation, 2012
- Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI SeverityPLOS ONE, 2012
- Levodopa Response Reveals Sepiapterin Reductase Deficiency in a Female Heterozygote with AdrenoleukodystrophyJIMD Reports, 2011
- Antioxidants halt axonal degeneration in a mouse model of X‐adrenoleukodystrophyAnnals of Neurology, 2011
- Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypesneurogenetics, 2010
- Current and Future Pharmacological Treatment Strategies in X‐Linked AdrenoleukodystrophyBrain Pathology, 2010
- The role of ELOVL1 in very long‐chain fatty acid homeostasis and X‐linked adrenoleukodystrophyEMBO Molecular Medicine, 2010
- Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophyHuman Molecular Genetics, 2005